Innoviva shareholders back directors, 2026 equity plan
Innoviva, Inc. reported results from its Annual Meeting of Stockholders held on May 4, 2026.
Rhea-AI Filing Summary
Innoviva, Inc. reported results from its Annual Meeting of Stockholders held on May 4, 2026. Stockholders elected five directors for one-year terms ending at the 2027 annual meeting, including Chief Executive Officer Pavel Raifeld, with each nominee receiving a strong majority of votes cast.
Stockholders approved, on a non-binding advisory basis, Innoviva’s executive compensation and ratified the Audit Committee’s selection of Deloitte & Touche LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026. They also approved Innoviva’s 2026 Equity Incentive Plan, supporting the company’s ongoing compensation and governance framework.
Positive
- None.
Negative
- None.
8-K Event Classification
Item 5.07 — Submission of Matters to a Vote of Security Holders
1 item
Item 5.07
Submission of Matters to a Vote of Security Holders
Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Key Figures
Say-on-pay support: 56,243,880 shares for
Say-on-pay opposition: 2,836,001 shares against
Auditor ratification votes for: 66,008,453 shares for
+3 more
6 metrics
Say-on-pay support
56,243,880 shares for
Non-binding advisory vote on executive compensation
Say-on-pay opposition
2,836,001 shares against
Non-binding advisory vote on executive compensation
Auditor ratification votes for
66,008,453 shares for
Ratification of Deloitte & Touche LLP for fiscal year ending December 31, 2026
2026 Equity Plan approval
55,435,111 shares for
Approval of Innoviva’s 2026 Equity Incentive Plan
Votes for Pavel Raifeld
58,880,013 shares for
Election to board of directors for term expiring at 2027 annual meeting
Broker non-votes
6,809,010 shares
Reported on multiple voting items at the annual meeting
Key Terms
non-binding advisory basis, broker non-votes, independent registered public accounting firm, 2026 Equity Incentive Plan, +1 more
5 terms
non-binding advisory basis regulatory
"our stockholders next approved on a non-binding advisory basis, Innoviva’s executive compensation"
A non-binding advisory basis is guidance or a recommendation offered for informational purposes that does not create legal obligations or guarantees; recipients can accept, modify, or ignore it without contractual consequences. Investors should treat it like a weather forecast for planning—useful for forming expectations and assessing risk, but not a firm promise—so they should verify assumptions, seek confirming information, and avoid relying on it as the sole basis for investment decisions.
broker non-votes financial
"and 6,809,010 shares of broker non-votes"
Broker non-votes occur when a brokerage firm is unable to vote on a shareholder’s behalf during a company election or decision because the shareholder has not given specific voting instructions, and the broker is not allowed or chooses not to vote on certain matters. They are important because they can affect the outcome of votes, especially when the results are close, by effectively reducing the total number of votes cast.
independent registered public accounting firm regulatory
"as our independent registered public accounting firm for the fiscal year ending December 31, 2026"
An independent registered public accounting firm is an outside accounting company officially registered with the government regulator to examine and report on a public company's financial records and controls. Investors treat its reports like an impartial inspector’s certificate — they add credibility to financial statements, help spot errors or misleading claims, and reduce the risk that shareholders are relying on unchecked or biased numbers.
2026 Equity Incentive Plan financial
"our stockholders also approved Innoviva’s 2026 Equity Incentive Plan"
Annual Meeting of Stockholders regulatory
"At the Annual Meeting of Stockholders held on May 4, 2026"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What is Innoviva’s 2026 Equity Incentive Plan and how was it approved?
Innoviva’s 2026 Equity Incentive Plan is a stock-based compensation program approved by shareholders at the annual meeting. The proposal received 55,435,111 shares for, 3,766,788 shares against and 36,028 abstentions, plus 6,809,010 broker non-votes, supporting continued equity-based incentives for eligible participants.
Who was elected to Innoviva’s board of directors at the 2026 annual meeting?
Five directors were elected for one-year terms expiring at the 2027 annual meeting: Derek Small, Mark A. DiPaolo, Esq., Jules Haimovitz, Sarah J. Schlesinger, M.D., and Chief Executive Officer Pavel Raifeld. Each director received a majority of votes cast, with additional broker non-votes recorded.
How strong was support for Innoviva CEO Pavel Raifeld’s board election in 2026?
Support for CEO Pavel Raifeld’s election as director was high. He received 58,880,013 shares voted for and 357,914 shares voted against or abstaining, along with 6,809,010 broker non-votes, indicating clear backing from voting shareholders at the 2026 annual meeting.
AI-generated analysis. How Rhea-AI works. Not financial advice.
